Royal Bank Of Canada Agios Pharmaceuticals, Inc. Transaction History

Royal Bank Of Canada

  • $479 Billion
  • Q4 2024

A detailed history of Royal Bank Of Canada transactions in Agios Pharmaceuticals, Inc. stock. As of the latest transaction made, Royal Bank Of Canada holds 34,343 shares of AGIO stock, worth $949,927. This represents 0.0% of its overall portfolio holdings.

Number of Shares
34,343
Previous 38,142 9.96%
Holding current value
$949,927
Previous $1.69 Million 33.41%
% of portfolio
0.0%
Previous 0.0%

Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 14, 2025
SELL
$32.86 - $61.64 $124,835 - $234,170
-3,799 Reduced 9.96%
34,343 $1.13 Million
Q3 2024

Nov 14, 2024
SELL
$41.19 - $49.72 $149,519 - $180,483
-3,630 Reduced 8.69%
38,142 $1.69 Million
Q2 2024

Aug 14, 2024
SELL
$27.55 - $48.83 $245,993 - $436,003
-8,929 Reduced 17.61%
41,772 $1.8 Million
Q1 2024

Nov 05, 2024
BUY
$21.32 - $34.81 $190,366 - $310,818
8,929 Added 21.38%
50,701 $1.48 Million
Q1 2024

May 15, 2024
SELL
$21.32 - $34.81 $124,572 - $203,394
-5,843 Reduced 10.33%
50,701 $1.48 Million
Q4 2023

Feb 14, 2024
BUY
$19.97 - $24.53 $50,823 - $62,428
2,545 Added 4.71%
56,544 $1.26 Million
Q3 2023

Nov 14, 2023
BUY
$24.36 - $28.18 $100,606 - $116,383
4,130 Added 8.28%
53,999 $1.34 Million
Q2 2023

Aug 14, 2023
BUY
$21.38 - $29.19 $105,745 - $144,373
4,946 Added 11.01%
49,869 $1.41 Million
Q1 2023

May 15, 2023
SELL
$21.74 - $30.93 $12,565 - $17,877
-578 Reduced 1.27%
44,923 $1.03 Million
Q4 2022

Feb 14, 2023
BUY
$24.81 - $31.52 $98,247 - $124,819
3,960 Added 9.53%
45,501 $1.28 Million
Q3 2022

Nov 14, 2022
BUY
$19.51 - $34.14 $187,588 - $328,256
9,615 Added 30.12%
41,541 $1.18 Million
Q2 2022

Aug 15, 2022
BUY
$17.06 - $31.42 $113,210 - $208,503
6,636 Added 26.24%
31,926 $708,000
Q1 2022

May 16, 2022
SELL
$26.68 - $34.81 $87,377 - $114,002
-3,275 Reduced 11.47%
25,290 $735,000
Q4 2021

Feb 14, 2022
SELL
$29.58 - $49.78 $58,183 - $97,917
-1,967 Reduced 6.44%
28,565 $940,000
Q3 2021

Nov 15, 2021
BUY
$41.92 - $58.18 $254,286 - $352,919
6,066 Added 24.79%
30,532 $1.41 Million
Q2 2021

Aug 16, 2021
BUY
$52.06 - $61.27 $1.27 Million - $1.5 Million
24,466 New
24,466 $1.35 Million

Others Institutions Holding AGIO

# of Institutions
243
Shares Held
59.9M
Call Options Held
270K
Put Options Held
332K
View Full List

About AGIOS PHARMACEUTICALS, INC.

AGIO Quotes by TradingView
  • Ticker AGIO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 54,818,000
  • Market Cap $1.52B
  • Description
  • Agios Pharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery and development of medicines in the field of cellular metabolism and adjacent areas of biology. The company offers PYRUKYND (mitapivat) an activator of both wild-type and a variety of mutant pyruvate kinase, PK, enzymes for the treatment of hemolytic anemias; and ...
More about AGIO
Track This Portfolio

Track Royal Bank Of Canada Portfolio

Follow Royal Bank Of Canada and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Royal Bank Of Canada, based on Form 13F filings with the SEC.

News

Stay updated on Royal Bank Of Canada with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email